Goldman Sachs
ONEM

Goldman Sachs’s 1Life Healthcare ONEM Stock Holding History

Goldman Sachs’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,059,700
Closed -$51.1M – 6442
2022
Q4 		$51.1M Buy
3,059,700
+620,364
+25% +$10.5M 0.01% 1154
2022
Q3 		$41.8M Sell
2,439,336
-809,166
-25% -$12.7M 0.01% 1241
2022
Q2 		$25.5M Buy
3,248,502
+218,488
+7% +$1.88M 0.01% 1697
2022
Q1 		$33.6M Buy
3,030,014
+849,166
+39% +$9.51M 0.01% 1642
2021
Q4 		$38.3M Buy
2,180,848
+164,420
+8% +$3.19M 0.01% 1559
2021
Q3 		$40.8M Buy
2,016,428
+570,773
+39% +$14.7M 0.01% 1440
2021
Q2 		$47.8M Buy
1,445,655
+434,456
+43% +$16.4M 0.01% 1301
2021
Q1 		$39.5M Sell
1,011,199
-108,915
-10% -$5.11M 0.01% 1356
2020
Q4 		$48.9M Sell
1,120,114
-95,267
-8% -$3.25M 0.01% 1144
2020
Q3 		$34.5M Buy
1,215,381
+1,100,672
+960% +$34.8M 0.01% 1293
2020
Q2 		$4.17M Sell
114,709
-191,830
-63% -$5.4M ﹤0.01% 2935
2020
Q1 		$5.56M Buy
+306,539
New +$6.72M ﹤0.01% 2555

Goldman Sachs's ONEM Position: Q1 2023 in Review

Goldman Sachs sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 3,059,700 shares — an estimated $51.1M sold.

Goldman Sachs first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $51.1M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Goldman Sachs reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Goldman Sachs sold 3,059,700 1Life Healthcare shares in Q1 2023, an estimated $51.1M.
  • Goldman Sachs first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Goldman Sachs's 1Life Healthcare position peaked at $51.1M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.